Subedi Suresh, Moonens Kristof, Romão Ema, Lo Alvin, Vandenbussche Guy, Bugaytsova Jeanna, Muyldermans Serge, Borén Thomas, Remaut Han
Structural and Molecular Microbiology, VIB Department of Structural Biology, VIB, Pleinlaan 2, 1050 Brussels, Belgium.
Research Group Cellular and Molecular Immunology, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium.
Acta Crystallogr F Struct Biol Commun. 2014 Dec 1;70(Pt 12):1631-5. doi: 10.1107/S2053230X14023188. Epub 2014 Nov 14.
Helicobacter pylori is a human pathogen that colonizes about 50% of the world's population, causing chronic gastritis, duodenal ulcers and even gastric cancer. A steady emergence of multiple antibiotic resistant strains poses an important public health threat and there is an urgent requirement for alternative therapeutics. The blood group antigen-binding adhesin BabA mediates the intimate attachment to the host mucosa and forms a major candidate for novel vaccine and drug development. Here, the recombinant expression and crystallization of a soluble BabA truncation (BabA(25-460)) corresponding to the predicted extracellular adhesin domain of the protein are reported. X-ray diffraction data for nanobody-stabilized BabA(25-460) were collected to 2.25 Å resolution from a crystal that belonged to space group P21, with unit-cell parameters a = 50.96, b = 131.41, c = 123.40 Å, α = 90.0, β = 94.8, γ = 90.0°, and which was predicted to contain two BabA(25-460)-nanobody complexes per asymmetric unit.
幽门螺杆菌是一种人类病原体,全球约50%的人口受其感染,可引发慢性胃炎、十二指肠溃疡甚至胃癌。多种抗生素耐药菌株的不断出现构成了重大的公共卫生威胁,因此迫切需要替代疗法。血型抗原结合黏附素BabA介导与宿主黏膜的紧密附着,是新型疫苗和药物开发的主要候选对象。本文报道了对应于该蛋白预测的细胞外黏附结构域的可溶性BabA截短体(BabA(25 - 460))的重组表达和结晶。从属于空间群P21的晶体中收集了纳米抗体稳定化的BabA(25 - 460)的X射线衍射数据,分辨率为2.25 Å,晶胞参数a = 50.96、b = 131.41、c = 123.40 Å,α = 90.0、β = 94.8、γ = 90.0°,预计每个不对称单元包含两个BabA(25 - 460)-纳米抗体复合物。